Assetmark Inc. lessened its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 6.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 645,728 shares of the financial services provider's stock after selling 42,855 shares during the period. Assetmark Inc. owned approximately 0.13% of Marsh & McLennan Companies worth $119,795,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MRSH. Assenagon Asset Management S.A. increased its position in Marsh & McLennan Companies by 9,455.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,520,164 shares of the financial services provider's stock valued at $282,021,000 after buying an additional 1,504,255 shares in the last quarter. Wellington Management Group LLP increased its position in Marsh & McLennan Companies by 9.1% during the 3rd quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider's stock valued at $3,041,386,000 after buying an additional 1,260,434 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in Marsh & McLennan Companies by 654.7% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,419,104 shares of the financial services provider's stock valued at $285,992,000 after buying an additional 1,231,059 shares in the last quarter. Invesco Ltd. increased its position in Marsh & McLennan Companies by 29.7% during the 3rd quarter. Invesco Ltd. now owns 3,293,188 shares of the financial services provider's stock valued at $663,676,000 after buying an additional 753,828 shares in the last quarter. Finally, Voloridge Investment Management LLC increased its position in Marsh & McLennan Companies by 93.4% during the 3rd quarter. Voloridge Investment Management LLC now owns 1,379,436 shares of the financial services provider's stock valued at $277,998,000 after buying an additional 666,023 shares in the last quarter. Institutional investors own 87.99% of the company's stock.
Insiders Place Their Bets
In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.38% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have commented on MRSH shares. Evercore reduced their target price on Marsh & McLennan Companies from $237.00 to $236.00 and set an "outperform" rating for the company in a report on Wednesday, January 7th. Cantor Fitzgerald raised their price target on Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an "overweight" rating in a research note on Monday, February 2nd. Citigroup raised their price target on Marsh & McLennan Companies from $201.00 to $205.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 3rd. Morgan Stanley dropped their price target on Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating on the stock in a research note on Monday, April 6th. Finally, Wells Fargo & Company dropped their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $205.60.
Check Out Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Performance
NYSE MRSH opened at $173.47 on Tuesday. The stock has a market capitalization of $83.98 billion, a P/E ratio of 20.58, a PEG ratio of 2.29 and a beta of 0.75. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 1.20. The firm's fifty day moving average is $173.02. Marsh & McLennan Companies, Inc. has a fifty-two week low of $164.89 and a fifty-two week high of $239.34.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion for the quarter, compared to the consensus estimate of $6.52 billion. Marsh & McLennan Companies had a return on equity of 31.60% and a net margin of 15.42%.Marsh & McLennan Companies's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.87 earnings per share. On average, sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.
Marsh & McLennan Companies Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a dividend of $0.90 per share. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies's payout ratio is 42.70%.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report